Giuseppe Rossi's fluctuant career has taken another downturn. After seeing a highly promising start cut short by a series of injuries, the former Villarreal, Celta and Levante forward has now tested positive in an anti-doping control conducted after Benevento's meeting with Genoa back in May, La Gazzetta dello Sport reports.
Traces of the banned substance dorzolamide was detected in the player's urine following the control on 12 May. Dorzolamide is a carbonic anhydrase inhibitor - frequently found in medication to treat glaucoma as it reduces intraocular pressure inside the eye.
It also features on the list of banned substances drawn up by the World Anti-Doping Agency (WADA), under the diuretics and masking agents category. Rossi, who has not been suspended for the time being, insists that he has not used eye drops - which could be the source of the dorzolamide found in his urine sample. The Italian Anti-Doping Agency are calling for a one-year suspension but a final verdict will be reached after the case is dealt with on 1 October.